• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

January 27, 2025

Study Links Racism With Increased Risk of High Postpartum Blood Pressure

Author(s):

Ashley Gallagher, Editor

Key Takeaways

  • Structural and interpersonal racism are associated with increased postpartum blood pressure, exacerbating racial and ethnic disparities in maternal health outcomes.
  • Gendered racial microaggressions significantly impact postpartum blood pressure, with stronger associations observed in the later postpartum period.
  • The study emphasizes the need for healthcare professionals to focus on maternal health equity and extend blood pressure monitoring and interventions beyond the immediate postpartum period.
  • Synergistic effects of microaggressions and structural racism can lead to significantly higher systolic blood pressure, highlighting the need for comprehensive hypertension management.
SHOW MORE

Although the research focused on Black communities in the United States, there is also evidence linking racism and blood pressure for patients who are Asian or Hispanic.

Structural racism, as well as interpersonal racism, have been associated with an increase in postpartum blood pressure, potentially linking inequalities to postpartum morbidity, mortality, and cardiovascular diseases, according to results of a study published in Hypertension.1

Postpartum Blood Pressure, Racism | Image Credit: Rido | stock.adobe.com

Postpartum Blood Pressure, Racism | Image Credit: Rido | stock.adobe.com

"It is well-known that Black, Hispanic, and South Asian women experience microaggressions during health care. It is not as well known whether these microaggressions may have an association with higher blood pressure,” Teresa Janevic, PhD, MPH, an associate professor of epidemiology at Columbia University Mailman School of Public Health in New York, said in a news release.2

According to the study authors, postpartum hypertension has become a key factor in racial and ethnic inequalities for maternal mortality. They report that the maternal mortality rate was 2- to 3-times higher for Black birthing patients compared with non-Hispanic White birthing patients. Although there is research focusing on Black people in the United States, there is also evidence suggesting the association of racism and blood pressure for patients who are Asian or Hispanic. The authors note that there is limited evidence of this association in the postpartum period.1

Investigators compiled data from 4 maternity hospitals in New York City and Philadelphia. Birthing patients with and without hypertensive disorders of pregnancy (HDP) were included to determine associations between gendered racial microaggressions and postpartum blood pressure. There were 373 birthing individuals included in the study, with recruiting taking place before postpartum discharge between March 2022 and October 2022. Individuals were followed for 3 months; were Asian, Black, or Hispanic; and had a cell phone.1

Individuals evaluated their blood pressure twice a day and texted the results via a cellphone for 10 days, then twice weekly for days 11 through 90. To evaluate gendered racial microaggressions (GRM), investigators used the Gendered Racial Microaggression Scale (GRMS), which included 26 items on a frequency scale of 0 (never) to 5 (once per week or more). Furthermore, investigators used the Structural Racism Effect Index (SREI) to measure place-based structural racism., including 9 domains of built environment, criminal justice, education, employment, housing, income and poverty, social cohesion, transportation, and wealth.

The full study sample was comprised of 10.5% Asian individuals, 38.6% Black individuals, 40% Hispanic individuals, and 11% who reported another race or ethnicity. Approximately 52.9% were foreign born, according to the study investigators. There were 15% who had less than a high school diploma, 34.3% who had a high school diploma or General Education Development, 24.1% had some college, and 24.4% had a bachelor’s degree or higher.1

Approximately 37.5% of patients reported at least 1 GRM, and those patients had a higher 3-month postpartum mean systolic blood pressure of 120.6 mm Hg and diastolic blood pressure of 74.5 mm Hg compared with 118.47 mm Hg and 73.08 mm Hg for those who did not experience GRM. For the adjusted model, including race–ethnicity, education, body mass index, chronic hypertension, age, and SREI, the systolic blood pressure was 1.98 mmHg and diastolic was 1.21 mm Hg. Investigators also used a model spline for 2 postpartum time periods, 1 to 11 days and 12 to 83.5 days, which showed significant differences for the later period compared with the earlier period. The adjusted systolic blood pressure and diastolic blood pressure was 1.81 mm Hg and 1.15 mm Hg for the first period, respectively, and 2.13 mm Hg and 1.26 mm Hg for the later period.1

“It’s surprising the associations were strongest in the later postpartum period between 12 days and 3 months after delivery. This is an emerging critical period for preventing high blood pressure,” Janevic said in the news release. “Our findings provide further evidence that health care professionals and policies should focus more intensely on improving maternal health care equity. We need high blood pressure monitoring and interventions to extend further into the period after birth when blood pressure may continue to be sensitive to social drivers of health as well as racial microaggressions.”2

Additionally, 4.6% of individuals had chronic hypertension, 20.9% had pregnancy hypertension, and 13.4% had preeclampsia. Investigators reported that GRM differences in blood pressure were greater for those with HDP but were not statistically significant. The highest mean postpartum blood pressure among those who experienced GRM lived in a neighborhood with high SREI and those with the lowest 3-month mean lived in a neighborhood with low SREI and did not experience GRM.1

“The synergistic effects of experiencing gendered racial microaggressions and high levels of place-based structural racism were profound, resulting in a nearly 8 mm Hg higher systolic blood pressure. For many people, this can make the difference between needing blood pressure lowering medications or not,” Natalie A. Cameron, MD, MPH, an internal medicine specialist and instructor in preventive medicine at Northwestern University’s Feinberg School of Medicine, said in a news release. “These results emphasize that hypertension management needs to extend beyond prescription medications.”2

REFERENCES
1. Janevic T, Howell FM, Burdick M, et al. Racism and Postpartum Blood Pressure in a Multiethnic Prospective Cohort. Hypertension. Published online January 9, 2025. doi:10.1161/HYPERTENSIONAHA.124.23772
2. Race- and gender-based microaggressions linked to higher post-birth blood pressure. News release. American Heart Association. January 9, 2025. Accessed January 13, 2025. https://newsroom.heart.org/news/race-and-gender-based-microaggressions-linked-to-higher-post-birth-blood-pressure
Related Videos
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Related Content
Advertisement
Raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
May 29th 2025

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

Sharon Zhu, PharmD, BCGP, corresponding author Veronica Sozio, PharmD, BCPS Rachel L. Quinn, PharmD, BCACP, AE-C, CDCES
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
vitamins and supplements background - Image credit: MarekPhotoDesign.com | stock.adobe.com
May 29th 2025

Condition Watch: Vitamins

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
FDA approval -- Image credit: Inovo Lab | stock.adobe.com
Published: May 29th 2025 | Updated: May 29th 2025

FDA Approves Khindivi, First Oral Solution of Hydrocortisone, for Pediatric Patients

Gillian McGovern, Associate Editor
Infectious viruses such as respiratory syncytial virus (RSV) causing respiratory infections - Image credit: Artur | stock.adobe.com
May 29th 2025

Study Reveals Impact of RSV on the Heart

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
May 29th 2025

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

Sharon Zhu, PharmD, BCGP, corresponding author Veronica Sozio, PharmD, BCPS Rachel L. Quinn, PharmD, BCACP, AE-C, CDCES
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
vitamins and supplements background - Image credit: MarekPhotoDesign.com | stock.adobe.com
May 29th 2025

Condition Watch: Vitamins

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
FDA approval -- Image credit: Inovo Lab | stock.adobe.com
Published: May 29th 2025 | Updated: May 29th 2025

FDA Approves Khindivi, First Oral Solution of Hydrocortisone, for Pediatric Patients

Gillian McGovern, Associate Editor
Infectious viruses such as respiratory syncytial virus (RSV) causing respiratory infections - Image credit: Artur | stock.adobe.com
May 29th 2025

Study Reveals Impact of RSV on the Heart

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.